Nanovis, Inc. announced the acquisition of certain of its nano surface technology assets and certain of its rights to intellectual property assets related to Sites Medical’s OsteoSync^TMTitanium and related polymer molding technologies (used in fixed height PEEK/OsteoSync interbodies) by Medtronic for use in the development of Medtronic’s next generation PEEK interbody fusion devices.

Microport is excited to announce the newest addition to the Evolution® Revision Knee family – Evolution® Tibial Cones. Designed to tackle the challenges of bone loss and poor bone quality encountered in complex revision knee surgeries, these versatile cones are made from OsteoSync® Ti and offer surgeons a reliable, efficient solution to improve patient outcomes.

SITES Medical in growth mode. In response to significantly increased demand for our OsteoSync Ti porous ingrowth technology, we’ve added six new, state-of-the-art wire EDM machines which are used in the manufacturing process.

Another milestone for OsteoSync Ti: Over 200,000 devices implanted. Our OEM partners have their own tradenames for it, but they all appreciate OsteoSync Ti for its best-in-class bone ingrowth, high initial stability and the ability to attach to various substrates, including Co-Cr and Ti.

SITES Medical celebrates its 15th anniversary. From humble beginnings and a focus on a singular technology, we have expanded our offering of platform technologies and added contract R&D and manufacturing services to provide a rapid product concept-to-launch process to support our OEM customers.

Spineology Inc., an innovator in anatomy-conserving surgery, is excited to launch the Duo Ti Expandable Interbody Fusion Procedure, which combines Spineology’s proprietary mesh technology with OsteoSync porous titanium to deliver a large, anatomy conforming implant via anatomy-conserving lateral decubitus and prone approaches.